Related Experiment Video
Updated: Jul 20, 2025
07:21
Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
Published on: June 27, 2025
59
Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis
Joel Adu-Brimpong1, Jennifer Pugh2, David Agyen Darko3
1School of Medicine, Stanford University, Stanford, CA, United States.
Journal of Medical Internet Research
|August 2, 2023
Summary
Digital therapeutics (DTx) clinical trials show underrepresentation of Black, Asian, and Hispanic populations. Improved sociodemographic diversity in DTx trials is crucial for equitable healthcare access and effective digital health therapies.
Area of Science:
- Digital health
- Clinical research
- Health equity
Background:
- Digital therapeutics (DTx) are software-based medical interventions transforming healthcare access and delivery.
- Ensuring equitable access requires examining sociodemographic representation in DTx clinical trials.
- Current DTx trials may not reflect the diverse populations they aim to serve.
Conclusions:
- DTx clinical trials present significant opportunities to enhance sociodemographic representation.
- Addressing underrepresentation, particularly among minority and underserved groups, is vital for equitable DTx application.
- This review provides critical insights for advancing inclusive DTx development and clinical validation.
Related Concept Videos
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:20Study Designs in Epidemiology
270
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
270
01:12Hazard Ratio
159
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
159
01:12Statistical Software for Data Analysis and Clinical Trials
627
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
627